Market Research Report
Germany Sleep Apnea Therapeutics and Diagnostics Market Forecast 2021-2026
|Published by||Inkwood Research||Product code||1018669|
|Published||Content info||144 Pages
Delivery time: 2-3 business days
|Germany Sleep Apnea Therapeutics and Diagnostics Market Forecast 2021-2026|
|Published: July 19, 2021||Content info: 144 Pages||
The Germany sleep apnea therapeutics and diagnostics market is set to register a CAGR of 6.47% during the forecast period, 2021-2026. The market growth is primarily driven by the presence of several respiratory care medical device companies and the high healthcare expenditure.
If left untreated, sleep-wake disorders like obstructive sleep apnea and insomnia can lead to severe health problems. One of the most common devices for sleep apnea treatment is continuous positive airway pressure. Germany is home to prominent sleep apnea devices companies like Itamar Medical Ltd, ResMed Inc, Medtronic PLC, Koninklijke Philips NV, etc. Also, the country is witnessing growing side-effects of urban lifestyle like diabetes, anxiety, technological advancements, and obesity, and a high prevalence of obstructive sleep apnea.
Due to the pandemic, the clinical testing of sleep apnea has been suspended. As per the European Respiratory Journal study on sleep apnea management during the pandemic in 2020, the clinical PSG testing number decreased to 20% from 92.5% across the sleep centers in Europe, including German Sleep Society Center. Moreover, teleconsultation has dipped from 30% to 27.5%. Such aspects constitute the German sleep apnea market.
Some of the eminent companies in the market are: GE Healthcare, Somnomedics GmbH, Invacare Corporation, Koninklijke Philips NV, Medtronic Plc, etc.